1-9 of 9
Thomas Rüdiger
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Oncogenic pathways in distinct DLBCL subgroups

Hans Konrad Müller-Hermelink, Thomas Rüdiger
Journal: Blood
Blood (2006) 107 (10): 3818.
https://doi.org/10.1182/blood-2006-03-005223
Published: 2006
Journal Articles

Transmembrane adaptor molecules: a new category of lymphoid-cell markers

Sara Tedoldi, Jennifer C. Paterson, Martin-Leo Hansmann, Yasodha Natkunam, Thomas Rüdiger, Pavla Angelisova, Ming Q. Du, Helen Roberton, Giovanna Roncador, Lydia Sanchez, Michela Pozzobon, Noraidah Masir, Richard Barry, Stefano Pileri, David Y. Mason, Teresa Marafioti, Václav Horejsí
Journal: Blood
Blood (2006) 107 (1): 213–221.
https://doi.org/10.1182/blood-2005-06-2273
Published: 2006
Journal Articles

Anaplastic large cell lymphomas lack the expression of T-cell receptor molecules or molecules of proximal T-cell receptor signaling

Brief Report
Irina Bonzheim, Eva Geissinger, Sabine Roth, Andreas Zettl, Alexander Marx, Andreas Rosenwald, Hans Konrad Müller-Hermelink, Thomas Rüdiger
Journal: Blood
Blood (2004) 104 (10): 3358–3360.
https://doi.org/10.1182/blood-2004-03-1037
Published: 2004
Journal Articles

Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell/histiocyte-rich B-cell lymphoma: differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma

Clinical Trials & Observations
Ludmila Boudová, Emina Torlakovic, Jan Delabie, Peter Reimer, Beate Pfistner, Sabine Wiedenmann, Volker Diehl, Hans-Konrad Müller-Hermelink, Thomas Rüdiger
Journal: Blood
Blood (2003) 102 (10): 3753–3758.
https://doi.org/10.1182/blood-2003-02-0626
Published: 2003
Journal Articles

Epstein-Barr virus–associated B-cell non-Hodgkin lymphoma following treatment of hairy cell leukemia with cladribine

Georg Lenz, Alexander Golf, Thomas Rüdiger, Wolfgang Hiddemann, Torsten Haferlach
Journal: Blood
Blood (2003) 102 (9): 3457–3458.
https://doi.org/10.1182/blood-2003-07-2494
Published: 2003
Journal Articles

Treatment of relapsed CD20 + Hodgkin lymphoma with the monoclonal antibody rituximab is effective and well tolerated: results of a phase 2 trial of the German Hodgkin Lymphoma Study Group

Clinical Trials & Observations
Ute Rehwald, Holger Schulz, Marcel Reiser, Markus Sieber, Jan Oliver Staak, Franck Morschhauser, Christoph Driessen, Thomas Rüdiger, Konrad Müller-Hermelink, Volker Diehl, Andreas Engert
Journal: Blood
Blood (2003) 101 (2): 420–424.
https://doi.org/10.1182/blood.V101.2.420
Published: 2003
Journal Articles

Paraneoplastic myasthenia gravis correlates with generation of mature naive CD4 + T cells in thymomas

Philipp Ströbel, Markus Helmreich, Georgios Menioudakis, Sharon R. Lewin, Thomas Rüdiger, Andrea Bauer, Viola Hoffacker, Ralf Gold, Wilfred Nix, Berthold Schalke, Olaf Elert, Michael Semik, Hans Konrad Müller-Hermelink, Alexander Marx
Journal: Blood
Blood (2002) 100 (1): 159–166.
https://doi.org/10.1182/blood.V100.1.159
Published: 2002
Journal Articles

Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma: 2 types of follicular lymphoma grade 3

German Ott, Tiemo Katzenberger, Andreas Lohr, Steffi Kindelberger, Thomas Rüdiger, Martin Wilhelm, Jörg Kalla, Andreas Rosenwald, Justus G. Müller, M. Michaela Ott, Hans Konrad Müller-Hermelink
Journal: Blood
Blood (2002) 99 (10): 3806–3812.
https://doi.org/10.1182/blood.V99.10.3806
Published: 2002
Journal Articles

Expression of CD94/NKG2A and killer immunoglobulin-like receptors in NK cells and a subset of extranodal cytotoxic T-cell lymphomas

Brief Report
Wolfgang Haedicke, Faith C. S. Ho, Andreas Chott, Lorenzo Moretta, Thomas Rüdiger, German Ott, Hans Konrad Müller-Hermelink
Journal: Blood
Blood (2000) 95 (11): 3628–3630.
https://doi.org/10.1182/blood.V95.11.3628
Published: 2000